Search hospitals > Michigan > Ann Arbor
C S Mott Children's Hospital
Claim this profileAnn Arbor, Michigan 48109
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Neuroblastoma
Conducts research for Recurrence
Conducts research for Lymphoma
370 reported clinical trials
23 medical researchers
Summary
C S Mott Children's Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Leukemia, Tumors, Neuroblastoma, Recurrence, Lymphoma and other specialties. C S Mott Children's Hospital is involved with conducting 370 clinical trials across 580 conditions. There are 23 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Carl Koschmann, MD, Rama Jasty, and Emily B. Walling.Area of expertise
1Leukemia
Global LeaderStage II
NTRK1 positive
NTRK positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Rajen Mody, MD, MSC S Mott Children's Hospital7 years of reported clinical research
Expert in Neuroblastoma
Expert in Tumors
50 reported clinical trials
82 drugs studied
Carl Koschmann, MDUniversity of Michigan2 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
11 reported clinical trials
18 drugs studied
Rama JastyC S Mott Children's Hospital6 years of reported clinical research
Studies Tumors
Studies Cancer
11 reported clinical trials
28 drugs studied
Emily B. WallingC S Mott Children's Hospital4 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
11 reported clinical trials
41 drugs studied
Clinical Trials running at C S Mott Children's Hospital
Brain Tumor
Osteosarcoma
Tumors
Acute Myeloid Leukemia
Lymphoma
Non-Hodgkin's Lymphoma
Germ Cell Tumors
Solid Tumors
Neuroblastoma
Acute Lymphoblastic Leukemia
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at C S Mott Children's Hospital?
C S Mott Children's Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Leukemia, Tumors, Neuroblastoma, Recurrence, Lymphoma and other specialties. C S Mott Children's Hospital is involved with conducting 370 clinical trials across 580 conditions. There are 23 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Carl Koschmann, MD, Rama Jasty, and Emily B. Walling.
Where is C S Mott Children's Hospital located?
**CS Mott Children's Hospital Location and Parking:**
- **Address:** 1540 East Medical Center Drive, Ann Arbor, MI.
- **Parking:** Available in structures P2, P3, and P4, with valet parking options.
Who should I call to ask about financial aid or insurance network?
For financial assistance at C.S. Mott Children's Hospital:
- Contact the Transplant Financial Coordinators at (734) 232-9984 or (800) 333-9013 for insurance-related inquiries.
- Michigan Medicine's MSupport program is available for those uninsured, insured but unable to afford out-of-pocket costs, or insured but receiving services not covered by insurance. Apply by contacting financial counselors at (855) 855-0863 or (734) 615-0863, completing an application, visiting the Patient Portal, or emailing [email protected].
- For general financial assistance information, call 800-988-6300.
What insurance does C S Mott Children's Hospital accept?
C.S. Mott Children's Hospital accepts a wide range of insurance plans, including but not limited to Medicaid, various Aetna plans (such as Aetna HMO, Aetna PPO, Aetna Premier Care Network), several BCBS plans across different states (like BCBS IL Blue Precision HMO, BCBS MI Blue Care Network HMO), and Anthem. For a comprehensive list of accepted insurance plans, please refer to their website. It is crucial to confirm your insurance details with the hospital or your doctor's office directly, as insurance coverage may change.
What awards or recognition has C S Mott Children's Hospital received?
C.S. Mott Children's Hospital, located in Ann Arbor, Michigan, is recognized as the top children's hospital in Michigan and ranks among the best in the nation according to U.S. News & World Report. It stands as the highest-ranking children's hospital in the state and is tied for third in the Midwest region, excelling across all 10 pediatric specialty areas evaluated. The University of Michigan, home to Mott Children's Hospital, leads in research expenditures among U.S. public universities and ranks in the top 3 for grant funding focused on children and adolescents, with over 200,000 children participating in more than 600 research studies.